戻る
NervGen Pharma Corp (NGENF)価格
NGENF 株価推移チャート
NGENF 収入
NervGen Pharma Corp
$5.63
2.92%
$0.16
終値： Jan 16, 16:00:00 GMT-5
$5.63
0%
$0
アフターマーケット：Jan 16, 20:00:00 GMT-5
主要データ
前終値
$5.47
始値
$5.3
当日レンジ
$5.3 - $5.81
52週レンジ
$1.5 - $6.3
取引高
27.4K
平均取引高
143.6K
1株当たり利益(TTM)
-0.26
配当利回り
--
時価総額
$445.9M
NGENFとは何ですか？
NervGen Pharma Corp. operates as a clinical stage biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2019-03-13. The firm is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.